Sarah Sinclair

Education

MA in Journalism from the University of Sunderland, NCTJ accreditation,

Experience

Editor of Cannabis Health (2019-2023); Contributor at Forbes (2023-present); Panel Moderator at Cannabis Europa, Product Earth, and Drug Science’s UK Patient Conference (2023); Reporter on women’s health, health technology, biotech, longevity, and neurorehabilitation medicine.

Written For

Forbes, Cannabis Health, Business of Cannabis, Drug Science.

Sarah is a highly respected journalist, with over a decade of experience in publishing and communications, the last four of which have been in specialist healthcare sectors. She is one of the few UK journalists specialising in cannabis-related health and policy, with work that spans the fields of science, medicine, wellness and drug policy. As the former editor of Cannabis Health, an industry-leading and award-winning title covering the potential of cannabis for health and wellbeing, she has been at the forefront of the UK medical cannabis sector for the last four years and has reported extensively, with a particular focus on patients and consumers. Under Sarah’s leadership, Cannabis Health won 'Best CBD Magazine' at the World CBD Awards 2022. She is now a regular contributor to Forbes, covering cannabis with a focus on Europe and has moderated panels at leading industry events, including Cannabis Europa, Product Earth and Drug Science’s UK Patient Conference, which she helped curate in November 2023. Beyond cannabis, Sarah also has experience reporting on women’s health, health technology, biotech, longevity and neurorehabilitation medicine. She has an NCTJ accreditation and graduated from her MA in Journalism at the University of Sunderland with a distinction. She has also completed specialist training through the Medical Cannabis Clinicians Society in the UK. Sarah is passionate about tackling stigma and misinformation with science, without losing sight of the importance of the patient experience. Through her journalism and content, she helps readers navigate complex topics in a way that resonates and aims to empower individuals to make informed decisions about their health and wellbeing, with accurate, evidence-based information.

Releaf articles

Medical cannabis: modern treatments for migraines

Because they affect around one in seven people, Migraine Awareness Week is a crucial initiative to spotlight the significant impact migraines have on millions of lives worldwide. With conventional treatments not always able to provide adequate relief, medical cannabis has emerged as a promising alternative.